WO2009041700A1 - Composition pharmaceutique - Google Patents
Composition pharmaceutique Download PDFInfo
- Publication number
- WO2009041700A1 WO2009041700A1 PCT/JP2008/067693 JP2008067693W WO2009041700A1 WO 2009041700 A1 WO2009041700 A1 WO 2009041700A1 JP 2008067693 W JP2008067693 W JP 2008067693W WO 2009041700 A1 WO2009041700 A1 WO 2009041700A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- stretch
- pharmaceutical composition
- composition
- nerve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition qui peut inhiber l'activité d'inhibition de l'étirement nerveux d'un composé 1 contenu dans cette composition ; et une composition capable de favoriser l'étirement nerveux, qui peut favoriser, de manière significative, l'étirement d'une cellule nerveuse. L'invention concerne ainsi une composition pharmaceutique caractérisée en ce qu'elle renferme un composé 1 et un composé 2 ; et une composition destinée à favoriser l'étirement nerveux, qui est caractérisée en ce qu'elle renferme au moins un composé 1 et un composé 2 et en ce qu'elle comprend en outre un composé 3.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-256016 | 2007-09-28 | ||
JP2007256016A JP5376785B2 (ja) | 2007-09-28 | 2007-09-28 | 医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009041700A1 true WO2009041700A1 (fr) | 2009-04-02 |
Family
ID=40511578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/067693 WO2009041700A1 (fr) | 2007-09-28 | 2008-09-29 | Composition pharmaceutique |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5376785B2 (fr) |
WO (1) | WO2009041700A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579584A (zh) * | 2011-01-06 | 2012-07-18 | 赵能 | 一种疏通经络治理面瘫的保健丸 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5376786B2 (ja) * | 2007-09-28 | 2013-12-25 | 小林製薬株式会社 | 神経細胞賦活組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001504104A (ja) * | 1996-11-06 | 2001-03-27 | ブリストル―マイヤーズ・スクイブ・カンパニー | アルツハイマー病の治療法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000057879A1 (fr) * | 1999-03-26 | 2000-10-05 | Barry Reisberg | Traitement des transformations intervenant dans le cerveau au moyen d'agents protegeant la myeline |
JP5376786B2 (ja) * | 2007-09-28 | 2013-12-25 | 小林製薬株式会社 | 神経細胞賦活組成物 |
-
2007
- 2007-09-28 JP JP2007256016A patent/JP5376785B2/ja not_active Expired - Fee Related
-
2008
- 2008-09-29 WO PCT/JP2008/067693 patent/WO2009041700A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001504104A (ja) * | 1996-11-06 | 2001-03-27 | ブリストル―マイヤーズ・スクイブ・カンパニー | アルツハイマー病の治療法 |
Non-Patent Citations (1)
Title |
---|
SWEENEY, C.J. ET AL.: "Two drug interaction studies evaluating the pharmacokinetics and toxicity of pemetrexed when coadministered with aspirin or Ibuprofen in patients with advanced cancer", CLIN CANCER RES, vol. 12, no. 2, 2006, pages 536 - 542 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579584A (zh) * | 2011-01-06 | 2012-07-18 | 赵能 | 一种疏通经络治理面瘫的保健丸 |
Also Published As
Publication number | Publication date |
---|---|
JP2009084207A (ja) | 2009-04-23 |
JP5376785B2 (ja) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008106128A3 (fr) | Inhibiteurs d'urée et de carbamate de 11b-hydroxystéroïde déshydrogénase 1 cycliques | |
IL219234A (en) | Pyrolidino Compounds [c – 4,3] Diprolidine Dual-Converted Positions n, n ', Pharmaceutical Preparations Containing and Uses | |
WO2008024497A3 (fr) | INHIBITEURS DE LA 11β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1 | |
WO2009075835A8 (fr) | Inhibiteurs cycliques d'urée de la 11-hydroxystéroïde déhydrogénase 1 | |
WO2010108074A3 (fr) | Inhibiteurs de pi3 kinase | |
MX2010005889A (es) | Derivados de tiofeno como agonistas de s1p1/edg1. | |
TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
TN2012000248A1 (en) | Novel spiropiperidine compounds | |
WO2010003133A3 (fr) | Modulateurs de cdk | |
WO2011014795A3 (fr) | Composés et compositions pouvant servir d'inhibiteurs de la kinase syk | |
WO2008103470A3 (fr) | Composés létaux dépendants du signal de ras oncogénique | |
SG179034A1 (en) | 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes | |
HK1133596A1 (en) | Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme | |
WO2008032191A3 (fr) | Composés spiro-oxazolidinone et leur utilisation comme potentialisateurs du récepteur métabotropique du glutamate | |
WO2008070268A3 (fr) | Compositions pharmaceutiques | |
MX2013005069A (es) | Formas cristalinas de sal de clorhidrato de (4a-r, 9a-s)-1-(1h-benzoimidazol-5-carbonil)-2,3,4,4a,9,9a,-hexahidro-1h -indeno[2,1-b]piridin-6-carbonitrilo y su uso como inhibidores de 11 beta-hidroxiesteroide deshidrogenasa 1. | |
WO2009038412A3 (fr) | Composés inhibiteurs de la béta-sécrétase | |
MY165041A (en) | Composition for improving brain function and method for improving brain function | |
WO2011088160A3 (fr) | Nouveaux inhibiteurs de cyp17 | |
WO2010123959A3 (fr) | Antagonistes ccr3 d'arylsulfonamides 2,5-disubstitués | |
WO2009129208A8 (fr) | Compositions et procédés permettant d'induire une réponse au stress du réticulum endoplasmique | |
WO2012075015A3 (fr) | Compositions pharmaceutiques orales de métronidazole | |
WO2010072770A3 (fr) | Analogues de griséofulvine pour le traitement du cancer par inhibition de l'agrégat centrosomial | |
TW200800993A (en) | Organic compounds | |
WO2009041700A1 (fr) | Composition pharmaceutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08834472 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08834472 Country of ref document: EP Kind code of ref document: A1 |